CHRONIC KIDNEY DISEASE STAGE3

Clinical trials for CHRONIC KIDNEY DISEASE STAGE3 explained in plain language.

Never miss a new study

Get alerted when new CHRONIC KIDNEY DISEASE STAGE3 trials appear

Sign up with your email to follow new studies for CHRONIC KIDNEY DISEASE STAGE3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 2 Terminated 1

Popular Weight-Loss drugs tested to protect kidneys from harmful fat

Disease control Recruiting now

This study is testing if GLP-1 receptor agonist drugs (like Ozempic or Wegovy) can help control chronic kidney disease by improving unhealthy fat tissue. Researchers will enroll 250 adults with kidney disease who also have type 2 diabetes, obesity, or heart disease. The main goal…

Matched conditions: CHRONIC KIDNEY DISEASE STAGE3

Sponsor: Cardenal Herrera University • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

CHRONIC KIDNEY DISEASE STAGE3

Get alerted when new CHRONIC KIDNEY DISEASE STAGE3 trials appear

Popular Weight-Loss drugs tested to protect kidneys from harmful fat